A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Bennett-Guerrero, Elliott, Grocott, Hilary P., Levy, Jerrold H., Stierer, Kevin A., Hogue, Charles W., Cheung, Albert T., Newman, Mark F., Carter, Alison A., Rossignol, Daniel P., Collard, Charles D.Volume:
104
Language:
english
Journal:
Anesthesia & Analgesia
DOI:
10.1213/01.ane.0000253501.07183.2a
Date:
February, 2007
File:
PDF, 195 KB
english, 2007